Contribution: Industrial Research Assistance Program – Contributions to Firms
CureImmune Therapeutics Inc.
$137,838.00
Preclinical development of bifunctional therapeutic agents for cancer immunotherapy
FY 2018-19 · 2018-06-01
Summary
The goal of the project is to develop broadly effective immune therapeutic agents for the treatment of cancer.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
783571292
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2019-05-31
Agreement Number
908737
Agreement Start Date
2018-06-01
Agreement Title
Preclinical development of bifunctional therapeutic agents for cancer immunotherapy
Agreement Title (French)
Développement préclinique d'agents théapeutiques bifonctionnels pour l'immunothérapie du cancer
Agreement Type
Contribution
Agreement Value
$137,838.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The goal of the project is to develop broadly effective immune therapeutic agents for the treatment of cancer.
Description (French)
L’objectif du projet est d’élaborer des agent thérapeutiques immunitaires largement efficace pour le traitement du cancer.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Granville
Federal Riding (French)
Vancouver Granville
Federal Riding Number
59036
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
783571292
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
CureImmune Therapeutics Inc.
Recipient Postal Code
V6P 6T3
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2018-2019-Q1-908737
